<DOC>
	<DOCNO>NCT00086255</DOCNO>
	<brief_summary>The purpose study assess tiagabine treatment cocaine dependence .</brief_summary>
	<brief_title>Tiagabine Treatment Cocaine Dependence - 1</brief_title>
	<detailed_description>To assess efficacy safety tiagabine reduce cocaine use subject cocaine dependence . It hypothesize tiagabine treatment , compare placebo , associate few day cocaine use assess self-report confirm urine assay benzoylecgonine ( BE ) . This double-blind , placebo-controlled , parallel-group design study , , screen 2-week baseline assessment period , subject equally randomly assign 1 2 treatment group , tiagabine match placebo .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Tiagabine</mesh_term>
	<criteria>Must least 18 year age seek treatment cocaine dependence . Have ability understand , understood , provide write informed consent . If female , agree use method birth control indicate clinician . Please contact participate site area information . Please contact participate site area information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>